J Andrew Carlson Selected Research

Pigmented Nevus (Melanocytic Nevus)

1/2018	CKS1 expression in melanocytic nevi and melanoma.
4/2017	TRPM1 (melastatin) expression is an independent predictor of overall survival in clinical AJCC stage I and II melanoma patients.
2/2011	Acquired primary cutaneous ganglioneuroma with adipocytic metaplasia: "An end point of melanocytic 'maturation'?" a case report and meta-analysis with comparison to a cross-sectional study of neurotized melanocytic nevi.
4/2010	The correlation of TRPM1 (Melastatin) mRNA expression with microphthalmia-associated transcription factor (MITF) and other melanogenesis-related proteins in normal and pathological skin, hair follicles and melanocytic nevi.
3/2003	Biomarkers in melanoma: predisposition, screening and diagnosis.
8/2002	Actin-binding protein fascin expression in skin neoplasia.
1/2002	Melanocytic proliferations associated with lichen sclerosus.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

J Andrew Carlson Research Topics

Disease

28	Neoplasms (Cancer) 03/2018 - 05/2002
19	Melanoma (Melanoma, Malignant) 01/2020 - 06/2002
7	Pigmented Nevus (Melanocytic Nevus) 01/2018 - 01/2002
6	Infections 08/2014 - 06/2002
6	Wounds and Injuries (Trauma) 11/2011 - 05/2002
5	Vasculitis (Vasculitides) 01/2018 - 09/2006
4	Carcinoma (Carcinomatosis) 03/2018 - 08/2002
4	Squamous Cell Carcinoma (Epidermoid Carcinoma) 01/2016 - 02/2004
4	Hyperpigmentation 01/2015 - 04/2002
4	Neoplasm Metastasis (Metastasis) 10/2013 - 08/2002
4	Purpura 04/2008 - 09/2006
4	Vascular Skin Diseases 01/2008 - 09/2006
3	Adenocarcinoma 06/2017 - 08/2002
3	Erythema 06/2015 - 12/2008
3	Dermatitis 01/2015 - 02/2007
3	Hyperplasia 01/2015 - 02/2007
3	Lymphedema (Milroy Disease) 09/2014 - 03/2007
3	Cicatrix (Scar) 04/2013 - 04/2002
3	Endarteritis 04/2013 - 02/2007
3	Warts (Wart) 04/2011 - 08/2008
3	Necrosis 08/2010 - 08/2004
3	Epidermodysplasia Verruciformis 08/2008 - 02/2007
2	Systemic Vasculitis 01/2018 - 01/2008
2	Rosacea (Acne Rosacea) 01/2017 - 07/2013
2	Ectropion 01/2017 - 06/2011
2	Syphilis 06/2015 - 07/2011
2	Nevus (Nevi) 10/2012 - 08/2008
2	Whipple Disease (Whipple's Disease) 04/2012 - 02/2009
2	Cysts 08/2011 - 08/2010
2	Erythema elevatum diutinum 01/2010 - 02/2007
2	Virus Diseases (Viral Diseases) 12/2009 - 02/2006
2	Skin Diseases (Skin Disease) 02/2009 - 09/2006
2	Malnutrition (Nutritional Deficiencies) 02/2009 - 02/2007
2	Arteritis 04/2008 - 02/2007
2	Vulvitis 03/2008 - 10/2003
2	Churg-Strauss Syndrome (Allergic Angiitis) 01/2008 - 09/2006
2	Rheumatoid Vasculitis 01/2008 - 09/2006
2	Granulomatosis with Polyangiitis (Wegener's Granulomatosis) 01/2008 - 09/2006
1	Basal Cell Carcinoma (Rodent Ulcer) 03/2018
1	IgA Vasculitis (Purpura, Schoenlein Henoch) 01/2018
1	Ataxia Telangiectasia (Louis Bar Syndrome) 01/2016
1	Neurofibromatosis 1 (Neurofibromatosis Type I) 01/2016
1	Spirochaetales Infections 06/2015
1	Lyme Disease (Disease, Lyme) 06/2015
1	Porokeratosis (Palmoplantar Porokeratosis) 01/2015
1	Lymphatic Metastasis 10/2013

Drug/Important Bio-Agent (IBA)

8	DNA (Deoxyribonucleic Acid)IBA 08/2014 - 06/2002
7	Proteins (Proteins, Gene)FDA Link 01/2018 - 02/2004
5	Antineutrophil Cytoplasmic Antibodies (ANCA)IBA 01/2018 - 09/2006
5	ParaffinIBA 01/2017 - 02/2004
5	Melanins (Melanin)IBA 06/2014 - 01/2002
4	Pharmaceutical PreparationsIBA 01/2018 - 02/2006
4	Adrenal Cortex Hormones (Corticosteroids)IBA 01/2015 - 09/2003
4	Formaldehyde (Formol)FDA Link 02/2013 - 02/2004
4	CollagenIBA 11/2011 - 01/2002
4	Biomarkers (Surrogate Marker)IBA 01/2005 - 03/2003
3	ErbB Receptors (EGF Receptor)IBA 01/2016 - 01/2007
3	Anti-Bacterial Agents (Antibiotics)IBA 06/2015 - 02/2006
2	Messenger RNA (mRNA)IBA 04/2017 - 04/2010
2	Phosphotransferases (Kinase)IBA 01/2017 - 10/2007
2	Cyclin D1IBA 01/2016 - 11/2011
2	FibrinIBA 04/2013 - 01/2010
2	Irritants (Vesicants)IBA 10/2012 - 12/2008
2	Periodic AcidIBA 04/2012 - 02/2009
2	Keratins (Keratin)IBA 08/2011 - 08/2010
2	Microphthalmia-Associated Transcription FactorIBA 02/2011 - 04/2010
2	Interferon Type IIBA 12/2009 - 02/2006
2	Plasminogen Activator Inhibitor 1IBA 01/2009 - 01/2007
2	Transforming Growth Factor beta (TGF-beta)IBA 01/2009 - 01/2007
2	HemosiderinIBA 04/2008 - 10/2003
2	Infliximab (Remicade)FDA Link 01/2008 - 09/2006
2	Rituximab (Mabthera)FDA Link 01/2008 - 09/2006
2	CytokinesIBA 01/2008 - 09/2006
2	Intravenous Immunoglobulins (IVIG)FDA Link 01/2008 - 09/2006
2	Fluconazole (Zonal)FDA LinkGeneric 04/2007 - 08/2004
2	Antigen-Antibody Complex (Immune Complex)IBA 02/2007 - 12/2006
2	AntibodiesIBA 02/2007 - 08/2002
2	Cyclin-Dependent Kinase Inhibitor p27IBA 11/2004 - 08/2004
1	Focal Adhesion Protein-Tyrosine KinasesIBA 01/2020
1	LigandsIBA 03/2018
1	3-(2-phenylethyl)-4-methylsydnoneIBA 08/2017
1	Serotonin (5 Hydroxytryptamine)IBA 03/2017
1	EndorphinsIBA 03/2017
1	ProteomeIBA 01/2017
1	Mitogen-Activated Protein KinasesIBA 01/2017
1	Ubiquitin-Protein Ligases (Ubiquitin-Protein Ligase)IBA 01/2016
1	Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA 01/2016
1	Doxycycline (Periostat)FDA LinkGeneric 06/2015
1	MucinsIBA 01/2015
1	Cell Adhesion MoleculesIBA 07/2013
1	Intercellular Adhesion Molecule-1 (Intercellular Adhesion Molecule 1)IBA 07/2013
1	Toll-Like Receptors (Toll-Like Receptor)IBA 07/2013

Therapy/Procedure

21	Therapeutics 01/2017 - 05/2003
2	Biological Therapy 01/2008 - 09/2006
2	Plasmapheresis 01/2008 - 09/2006
2	Transplantation 08/2007 - 05/2002
1	Operative Surgical Procedures 06/2017
1	Appendectomy 06/2017
1	Drug Therapy (Chemotherapy) 10/2013
1	Radiotherapy 10/2013